Interactions between tacrolimus and antimicrobial agents

Clinical Infectious Diseases

Volumn 25, Issue 6, 1997, Pages 1430-1440

  Paterson, David L ^a   Singh, Nina ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; ANTIMALARIAL AGENT; ANTIPARASITIC AGENT; ANTIRETROVIRUS AGENT; ANTIVIRUS AGENT; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN DERIVATIVE; CLARITHROMYCIN; CLOTRIMAZOLE; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; FLUCONAZOLE; FOSFOMYCIN; KETOCONAZOLE; LINCOMYCIN; MACROLIDE; MINOCYCLINE; PENEM DERIVATIVE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFABUTIN; RIFAMPICIN; TACROLIMUS; TEICOPLANIN; UNINDEXED DRUG; VACCINE; VANCOMYCIN;

BACTERIAL INFECTION; CLINICAL TRIAL; DRUG INHIBITION; DRUG POTENTIATION; GRAFT REJECTION; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALARIA; MYCOSIS; NEPHROTOXICITY; NEUROTOXICITY; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; TOPICAL DRUG ADMINISTRATION; VIRUS INFECTION;

EID: 0031466520     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/516138     Document Type: Review

References (7)

1. Peters DH, Fitton A, Plosker GL, Faulds D. Tacrolimus: a review of its pharmacology, and therapeutic potential in hepatic and renal transplantation. Drugs 1993;46:746-94.
2. The U.S. Multicenter FK506 Liver Study Group. A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 1994;331:1110-15.
3. European FK506 Multicentre Liver Study Group. Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. Lancet 1994;344:423-8.
4. Bäckman L, Nicar M, Levy M, et al. FK506 trough levels in whole blood and plasma in liver transplant recipients: correlation with clinical events and side effects. Transplantation 1994;57:519-25.
5. Winkler M, Jost U, Ringe B, Gubernatis G, Wonigeit K, Pichlmayr R. Association of elevated FK506 plasma levels with nephrotoxicity in liver-grafted patients. Transplant Proc 1991;23:3153-5.
6. Alessiani M, Cillo U, Fung JJ, et al. Adverse effects of FK 506 overdosage after liver transplantation. Transplant Proc 1993;25:628-34.
7. Jain AB, Todo S, Fung JJ, et al. Correlation of rejection episodes with FK506 dosage, FK506 level, and steroids following primary orthotopic liver transplant. Transplant Proc 1991;23:3023-5.